XELJANZ XR 11 mg/1

XELJANZ XR 11 mg is an extended-release tablet containing tofacitinib, used for managing specific inflammatory conditions. This medication is designed for oral administration and is manufactured by Pfizer Laboratories.

XELJANZ XR 11 mg is primarily used for the treatment of inflammatory conditions. It is often prescribed for managing symptoms associated with certain autoimmune disorders. Patients may wonder, 'What is XELJANZ XR used for?' This medication is intended to help reduce inflammation and improve quality of life for those with qualifying conditions.

Common effects of XELJANZ XR 11 mg may include mild to moderate gastrointestinal discomfort, headaches, and fatigue. Some users might experience changes in blood pressure or blood sugar levels. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

XELJANZ XR 11 mg should be handled with care, following the prescribed guidelines. It is essential to store the medication in a cool, dry place away from direct sunlight. Patients should avoid crushing or chewing the extended-release tablets to maintain their effectiveness.

XELJANZ XR 11 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and other substances that affect liver function should be avoided. Always inform your healthcare provider about all medications and supplements you are taking.